IPI. V. Predeina

I. V. Predeina

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


I. V. Predeina has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology

    by Marina Skorkina, Tatiana Kovaleva, Irina Predeina, Nikita Smirnov, Irina Mukhina

    Pax6 is a multifunctional transcription factor that orchestrates cell cycle progression at distinct stages of early embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways associated with pathological processes. Within this framework, Pax6 is regarded as an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The present review aims to examine published studies describing various Pax6-dependent molecular pathways to identify common principles and condition-specific differences in Pax6-regulated cascades in health and disease. These insights may contribute to the conceptual foundation for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data demonstrating a central role of Pax6 in governing the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.

  • Genetic characteristics of patients with left ventricular remodeling after ST-segment elevation myocardial infarction

    by K. V. Kuzmichev, I. G. Pochinka, A. A. Frolov, M. L. Budkina, N. A. Shchelchkova, V. I. Pershin, I. V. Predeina, N. S. Maksimova

    Aim. To identify genetic characteristics of patients with left ventricular remodeling (LVR) after ST-segment elevation myocardial infarction (STEMI) who underwent percutaneous coronary intervention (PCI) with reliable reperfusion. Material and methods. This single-center observational study included 40 patients with STEMI who successfully underwent PCI. Single nucleotide polymorphisms (SNPs) in genes involved in the renin-angiotensin-aldosterone system, coagulation cascade, platelet function, endothelial function, and folate metabolism were determined using real-time polymerase chain reaction (RT-PCR) with commercial kits. During follow-up, patients underwent echocardiography on days 1-3 and 7-14, as well as after 12-15 months. LVR was established according to following criteria: 1) combined echocardiographic criterion: a decrease in the left ventricular (LV) ejection fraction Results. Significant intergroup differences were identified for two following polymorphisms: rs5370 and rs1126643. In the group of patients with LVR, the frequency of rs5370 GG genotype was 91% (n=10) versus 40% (n=4) in the control group (p=0,024); the frequency of rs1126643 CC genotype was 67% (n=8) versus 8% (n=1), respectively (p=0,009). Multivariate regression analysis revealed that the reference rs5370 GG and rs1126643 CC genotypes may be associated with an increased risk of LVR in STEMI patients with achieved reperfusion, while carriage of an alternative allele (both homozygous and heterozygous) in at least one of these loci was protective. Conclusion. The reference rs5370 GG and rs1126643 CC genotypes may be part of a genetic predisposition to LVR in STEMI patients with successful reperfusion. These data are not exhaustive and require verification in larger studies.


  • Open Access

    Pax6 as a Therapeutic Target: Convergent Molecular Pathways in the Regulation of Aniridia, Neurogenesis, Neurodegeneration and Oncology

    by Marina Skorkina, Tatiana Kovaleva, Irina Predeina, Nikita Smirnov, Irina Mukhina

    The transcription factor Pax6 acts as a molecular switch regulating various phases of the cell cycle during the early stages of embryonic neurogenesis and serves as a molecular mediator integrating multiple signaling pathways involved in the development of pathophysiological conditions. In this regard, Pax6 is considered an attractive molecular target for developing new drugs aimed at combating neurodegeneration, oncology, and aniridia. The aim of this review is to examine the range of studies describing various Pax6-dependent molecular pathways to identify similarities and differences in the signaling cascades activated by Pax6 in health and disease. These insights may provide a basis for developing new therapeutic strategies targeting Pax6 as a molecular regulator. This review summarizes the data indicating the leading regulatory role of Pax6 in the neuronal cell cycle in health and pathology. It is possible that Pax6 may act as a therapeutic target in certain pathophysiological conditions; however, the effectiveness of such a strategy will depend on the substrate chain in the signaling pathway, its branching, and the redundancy of mediators involved.

  • Open Access

    Features of pea seed germination under the effect of an extract from the mycelium substrate for oyster mushroom cultivation

    by S. S. Tarasov, E. V. Mikhalev, E. K. Krutova, I. V. Predeina

    Background. The presented study demonstrates the ability of an aqueous extract from the used straw substrate for oyster mushrooms (hereinafter referred to as “the extract”) to regulate pea plant growth and development. Materials and methods. Experimental seeds of the pea cultivar ‘Albumen’ were soaked in 10% and 100% extracts and then cultivated for eight days on a hydroponic medium in the respective extract solutions and on soil (gray forest). The control plants were soaked in tap water, cultivated in it (hydroponics), and watered (soil). The extract’s effectiveness was assessed according to growth indicators, the content of photosynthetic pigments, and the expression of one of the genes encoding ribulose bisphosphate carboxylase/oxygenase activase ( RCA ) and two genes encoding isoamylase ( ISA-1 and ISA-2 ). Results. Inhibition of seed germination on the first day under the effect of 10% and 100% extracts was shown. Higher dry matter content and a decrease in the expression of all ISA genes were observed in the day-old germinating experimental seeds, indicating a slowdown in the initiation of seed germination. A decrease in the germination rate was recorded in the seeds cultivated with the 100% extract, while for those germinated with the 10% extract, this indicator did not differ from the control. The content of photosynthetic pigments in the experimental plant groups (100% concentration of the extract) grown in hydroponics was lower, and in those grown on soil, it was higher than in the control samples. Conclusion. The extract in both doses suppressed the germination of pea seeds and inhibited the growth and development of seedlings when cultivated on a hydroponic medium consisting of the extract. However, enhanced growth processes and increased expression of the studied genes were observed when pea plants were watered with the extract in a soil environment.

  • Open Access

    Genetic markers of endothelial dysfunction as predictors of coronary microvascular obstruction in endovascular treatment of myocardial infarction

    by A.A. Frolov, Nizhny Novgorod City Clinical Hospital No. 13 Of The Nizhny Novgorod Avtozavodsky District, I.G. Pochinka, K.V. Kuzmichev, N.A. Shchelchkova, V.I. Pershin, N.S. Maksimova, M.L. Budkina, I.V. Predeina, A.S. Mukhin

    Генетические маркеры эндотелиальной дисфункции как предикторы коронарной микрососудистой обструкции при эндоваскулярном лечении инфаркта миокарда